Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.

A traditional Chinese medicine formula (Fuzheng Yiliu decoction; FZYLD) has been used for many years in clinical settings to cure liver tumors; however, no empirical research has reported its chemical composition. In this paper, 21 chief constituents were distinguished from FZYLD using high-performance liquid chromatography-mass spectrometry fingerprint analysis. Molecular docking studies for B-cell lymphoma-extra large (Bcl-XL), interleukin (IL)-2, and tumor necrosis factor-α (TNF-α) were bound to evaluate their anticancer activities. 7 compounds showed potential Bcl-XL high affinity binding with a dissociate constant (Kd) < 10 μM; 7 compounds bound with IL-2 had a Kd < 10 μM; and 11 compounds showed potential TNF-α inhibition with a Kd < 10 μM. Moreover, 11 compounds showed better anticancer activity toward human HepG2 (hepatoma) cancer cell lines with IC50 values < 100 μM in vitro. The killings effects of natural killer cells can be activated by FZYLD on HepG2 cells and regulate the immune response through modulating IL-2 and TNF-α expression in vivo. In the "Fuzheng" Chinese medicine formula, many substances participate in the complex regulation of the immune network to execute the anti-tumor effect. The combination approach of chromatographic fingerprint and computer virtual docking used to explore active chemical matter of traditional Chinese medicine is extremely valuable.

[1]  R. Curi,et al.  Molecular Targets Related to Inflammation and Insulin Resistance and Potential Interventions , 2012, Journal of biomedicine & biotechnology.

[2]  Wen Chen,et al.  [Effect of Chinese herbal medicine on patients with primary hepatic carcinoma in III stage during perioperational period: a report of 42 cases]. , 2005, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

[3]  M. Iinuma,et al.  Natural Products for Medicine , 2012, Journal of biomedicine & biotechnology.

[4]  Zhisheng Wu,et al.  LC-MS–MS in MRM Mode for Detection and Structural Identification of Synthetic Hypoglycemic Drugs Added Illegally to ‘Natural’ Anti-Diabetic Herbal Products , 2009 .

[5]  Xinhua Lin,et al.  Chromatographic fingerprint and quantitative analysis of seven bioactive compounds of Scutellaria barbata. , 2011, Planta medica.

[6]  R. Rudolph,et al.  New Binding Mode to TNF-Alpha Revealed by Ubiquitin-Based Artificial Binding Protein , 2012, PloS one.

[7]  Jehun Choi,et al.  Anti-Inflammatory Cycloartane-Type Saponins of Astragalus membranaceus , 2013, Molecules.

[8]  M. Rosales-Hernández,et al.  Molecular modeling applied to anti-cancer drug development. , 2009, Anti-cancer agents in medicinal chemistry.

[9]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[10]  Tan Jing-wang.  Clinical Study of Chinese Herbs Combined with Operation on the Primary Hepatocarcinoma , 2005 .

[11]  D. Rodriguez-Amaya,et al.  HPLC-DAD-ESI/MS Identification and Quantification of Phenolic Compounds in Ilex paraguariensis Beverages and On-Line Evaluation of Individual Antioxidant Activity , 2013, Molecules.

[12]  R. Meadows,et al.  Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis , 1997, Science.

[13]  D. Sivakumar,et al.  In silico methods for designing antagonists to anti-apoptotic members of Bcl-2 family proteins. , 2012, Mini reviews in medicinal chemistry.

[14]  Jian Du,et al.  [Clinical study of Fuzheng Yiliu Recipe combined with microwave ablation on hepatocellular carcinoma]. , 2012, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

[15]  Aniko Simon,et al.  eHiTS: a new fast, exhaustive flexible ligand docking system. , 2007, Journal of molecular graphics & modelling.

[16]  Christopher L. McClendon,et al.  Reaching for high-hanging fruit in drug discovery at protein–protein interfaces , 2007, Nature.

[17]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[18]  S. Turk,et al.  Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based virtual screening. , 2013, European journal of medicinal chemistry.

[19]  Chen Li-wu.  Influence of Chinese Compound Prescription on Humoral Immune in Mice with Hepatic Carcinoma Transplanted Subcutaneously , 2007 .

[20]  Juan Hu,et al.  Antitussive Activity of Pseudostellaria heterophylla (Miq.) Pax Extracts and Improvement in Lung Function via Adjustment of Multi-Cytokine Levels , 2011, Molecules.

[21]  P. Wakeley,et al.  Synthesis , 2013, The Role of Animals in Emerging Viral Diseases.

[22]  Kalle Gehring,et al.  The discovery of small molecule chemical probes of Bcl-X(L) and Mcl-1. , 2008, Bioorganic & medicinal chemistry.

[23]  Aniko Simon,et al.  eHiTS: an innovative approach to the docking and scoring function problems. , 2006, Current protein & peptide science.

[24]  A. Tiwari,et al.  Synthesis, biological evaluation and molecular modeling studies of some novel thiazolidinediones with triazole ring. , 2013, European journal of medicinal chemistry.

[25]  A. Whitty,et al.  Small-molecule inhibition of TNF-alpha. , 2005, Science.

[26]  Michelle R. Arkin,et al.  Binding of small molecules to an adaptive protein–protein interface , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C G M Wilson,et al.  Small-molecule inhibitors of IL-2/IL-2R: lessons learned and applied. , 2011, Current topics in microbiology and immunology.

[28]  Judy Xu,et al.  Traditional Chinese medicine in the Chinese health care system , 2008, Health Policy.

[29]  이화영.  X , 1960, Chinese Plants Names Index 2000-2009.

[30]  Jun Wang,et al.  Small-Molecule Inhibition of TNF-α , 2005, Science.

[31]  Philippe Roche,et al.  Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I). , 2011, Current opinion in chemical biology.